Emer R McGrath1,2,3, Alan S Go4,5,6, Yuchiao Chang3,7, Leila H Borowsky7, Margaret C Fang8, Kristi Reynolds9, Daniel E Singer3,7. 1. Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts. 2. Department of Neurology, Brigham and Women's Hospital, Boston, Massachusetts. 3. Harvard Medical School, Boston, Massachusetts. 4. Division of Research, Kaiser Permanente of Northern California, Oakland, California. 5. Department of Medicine, Epidemiology and Biostatistics, University of California, San Francisco, California. 6. Departments of Health Research and Policy, Stanford University School of Medicine, Stanford, California. 7. Division of General Internal Medicine, Massachusetts General Hospital, Boston, Massachusetts. 8. Division of Hospital Medicine, University of California, San Francisco, California. 9. Department of Research and Evaluation, Kaiser Permanente of Southern California, Pasadena, California.
Abstract
OBJECTIVES: To explore barriers to anticoagulation in older adults with atrial fibrillation (AF) at high risk of stroke and to identify opportunities for interventions that might increase use of oral anticoagulants (OACs). DESIGN: Retrospective cohort study. SETTING: Two large community-based AF cohorts. PARTICIPANTS: Individuals with ischemic stroke surviving hospitalization (N = 1,405, mean age 79). MEASUREMENTS: Using structured chart review, reasons for nonuse of OAC were identified, and 1-year poststroke survival was assessed. Logistic regression was used to identify correlates of OAC nonuse. RESULTS: Median CHA2 DS2 -VASc score was 5, yet 44% of participants were not prescribed an OAC at discharge. The most-frequent (nonmutually exclusive) physician reasons for not prescribing OAC included fall risk (26.7%), poor prognosis (19.3%), bleeding history (17.1%), participant or family refusal (14.9%), older age (11.0%), and dementia (9.4%). Older age (odds ratio (OR) = 8.96, 95% confidence interval (CI) = 5.01-16.04 for aged ≥85 vs <65) and disability (OR = 12.58, 95% CI = 5.82-27.21 for severe vs no deficit) were the most-important independent predictors of nonuse of OACs. By 1 year, 42.5% of those not receiving an OAC at discharge had died, versus 19.1% of those receiving an OAC (P < .001), far higher than recurrent stroke rates. CONCLUSION: Despite very high stroke risk, more than 40% of participants were not discharged with an OAC. Dominant reasons included fall risk, poor prognosis, older age, and dementia. These individuals' high 1-year mortality rate confirmed their high level of comorbidity. To improve anticoagulation decisions and outcomes in this population, future research should focus on strategies to mitigate fall risk, improve assessment of risks and benefits of anticoagulation in individuals with AF, and determine whether newer anticoagulants are safer in complex elderly and frail individuals.
OBJECTIVES: To explore barriers to anticoagulation in older adults with atrial fibrillation (AF) at high risk of stroke and to identify opportunities for interventions that might increase use of oral anticoagulants (OACs). DESIGN: Retrospective cohort study. SETTING: Two large community-based AF cohorts. PARTICIPANTS: Individuals with ischemic stroke surviving hospitalization (N = 1,405, mean age 79). MEASUREMENTS: Using structured chart review, reasons for nonuse of OAC were identified, and 1-year poststroke survival was assessed. Logistic regression was used to identify correlates of OAC nonuse. RESULTS: Median CHA2 DS2 -VASc score was 5, yet 44% of participants were not prescribed an OAC at discharge. The most-frequent (nonmutually exclusive) physician reasons for not prescribing OAC included fall risk (26.7%), poor prognosis (19.3%), bleeding history (17.1%), participant or family refusal (14.9%), older age (11.0%), and dementia (9.4%). Older age (odds ratio (OR) = 8.96, 95% confidence interval (CI) = 5.01-16.04 for aged ≥85 vs <65) and disability (OR = 12.58, 95% CI = 5.82-27.21 for severe vs no deficit) were the most-important independent predictors of nonuse of OACs. By 1 year, 42.5% of those not receiving an OAC at discharge had died, versus 19.1% of those receiving an OAC (P < .001), far higher than recurrent stroke rates. CONCLUSION: Despite very high stroke risk, more than 40% of participants were not discharged with an OAC. Dominant reasons included fall risk, poor prognosis, older age, and dementia. These individuals' high 1-year mortality rate confirmed their high level of comorbidity. To improve anticoagulation decisions and outcomes in this population, future research should focus on strategies to mitigate fall risk, improve assessment of risks and benefits of anticoagulation in individuals with AF, and determine whether newer anticoagulants are safer in complex elderly and frail individuals.
Authors: Emily C O'Brien; DaJuanicia N Holmes; Jack E Ansell; Larry A Allen; Elaine Hylek; Peter R Kowey; Bernard J Gersh; Gregg C Fonarow; Christopher R Koller; Michael D Ezekowitz; Kenneth W Mahaffey; Paul Chang; Eric D Peterson; Jonathan P Piccini; Daniel E Singer Journal: Am Heart J Date: 2014-01-04 Impact factor: 4.749
Authors: Craig T January; L Samuel Wann; Joseph S Alpert; Hugh Calkins; Joaquin E Cigarroa; Joseph C Cleveland; Jamie B Conti; Patrick T Ellinor; Michael D Ezekowitz; Michael E Field; Katherine T Murray; Ralph L Sacco; William G Stevenson; Patrick J Tchou; Cynthia M Tracy; Clyde W Yancy Journal: J Am Coll Cardiol Date: 2014-03-28 Impact factor: 24.094
Authors: Brian F Gage; Elena Birman-Deych; Roger Kerzner; Martha J Radford; David S Nilasena; Michael W Rich Journal: Am J Med Date: 2005-06 Impact factor: 4.965
Authors: Emer R McGrath; Moira K Kapral; Jiming Fang; John W Eikelboom; Aengus ó Conghaile; Aengus O Conghaile; Michelle Canavan; Martin J O'Donnell Journal: Stroke Date: 2014-11-06 Impact factor: 7.914
Authors: Julian P Casciano; Daniel E Singer; Winghan Jacqueline Kwong; Eben S Fox; Bradley C Martin Journal: Am J Cardiovasc Drugs Date: 2012-10-01 Impact factor: 3.571
Authors: Jane S Saczynski; Saket R Sanghai; Catarina I Kiefe; Darleen Lessard; Francesca Marino; Molly E Waring; David Parish; Robert Helm; Felix Sogade; Robert Goldberg; Jerry Gurwitz; Weijia Wang; Tanya Mailhot; Benita Bamgbade; Bruce Barton; David D McManus Journal: J Am Geriatr Soc Date: 2019-10-01 Impact factor: 5.562
Authors: David R Vinson; E Margaret Warton; Dustin G Mark; Dustin W Ballard; Mary E Reed; Uli K Chettipally; Nimmie Singh; Sean Z Bouvet; Bory Kea; Patricia C Ramos; David S Glaser; Alan S Go Journal: West J Emerg Med Date: 2018-02-12
Authors: Steven A Lubitz; Shaan Khurshid; Lu-Chen Weng; Gheorghe Doros; Joseph Walker Keach; Qi Gao; Anil K Gehi; Jonathan C Hsu; Matthew R Reynolds; Mintu P Turakhia; Thomas M Maddox Journal: Am Heart J Date: 2018-03-10 Impact factor: 4.749
Authors: Sachin J Shah; Margaret C Fang; Sun Y Jeon; Steven E Gregorich; Kenneth E Covinsky Journal: J Am Geriatr Soc Date: 2020-09-28 Impact factor: 5.562